Indivior - Articles and news items

Positive top-line results from Phase 3 trial of RBP-7000 in schizophrenia announced

Industry news / 6 May 2015 / Victoria White

Indivior has announced top-line results from its Phase 3 clinical trial of RBP-7000, an investigational drug for the treatment of schizophrenia…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+